Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Predict SpAMIL:PRE 16 EV-to-EBIT is 18.94 as of Aug. 04, 2026, which is 144% above its 10-year median of 7.75. GuruFocus rates MIL:PRE with a GF Score™ of 16/100. The stock has 3 warning signs investors should review. Among 470 Medical Devices & Instruments companies, Predict SpA ranks better than 50.43% on this metric.
The historical rank and industry rank for Predict SpA's EV-to-EBIT or its related term are showing as below:
MIL:PRE'
s EV-to-EBIT Range Over the Past 10 Years
Min: 2.49 Med: 7.75 Max: 26.92
Current: 18.94
During the past 4 years, the highest EV-to-EBIT of Predict SpA was 26.92. The lowest was 2.49. And the median was 7.75.
MIL:PRE's EV-to-EBIT is ranked better than 50.43% of 470
companies
in the Medical Devices & Instruments industry
Industry Median: 18.985
vs MIL:PRE: 18.94
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Predict SpA's Enterprise Value for the quarter that ended in Dec. 2025 was €4.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Predict SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Predict SpA EV-to-EBIT Related Terms
Predict SpA EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Predict SpA's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Predict SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Predict SpA EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Predict SpA's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Predict SpA's EV-to-EBIT falls into.
Predict SpA's current Enterprise Value is €4.87 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Predict SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Predict SpA (MIL:PRE) has a EV-to-EBIT of 18.94 as of Aug. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Predict SpA and its competitors. This is 144% above median its historical median of 7.75. Over the past decade, Predict SpA's EV-to-EBIT has ranged from 2.49 to 26.92. According to the industry distribution chart, Predict SpA ranks #233 out of 470 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is Predict SpA's EV-to-EBIT too high?
Predict SpA's current EV-to-EBIT of 18.94 is 144% above median its 10-year median of 7.75. Over the past 10 years, this metric has ranged from a low of 2.49 to a high of 26.92. The Medical Devices & Instruments industry median EV-to-EBIT is 18.99. Predict SpA's value of 18.94 is 0.2% below this industry median. Based on the distribution chart, Predict SpA ranks #233 out of 470 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Predict SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Predict SpA's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Predict SpA ranks #233 out of 470 companies for EV-to-EBIT. This puts Predict SpA in the upper half of its industry. The industry median EV-to-EBIT is 18.99. Predict SpA's value of 18.94 is 0.2% below this benchmark. Historically, Predict SpA's own EV-to-EBIT has ranged from 2.49 to 26.92 over the past decade. While the company's 10-year median is 7.75 vs. the industry median of 18.99, Predict SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.99, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Predict SpA's current EV-to-EBIT of 18.94 is 0.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Predict SpA and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Predict SpA's current EV-to-EBIT is 18.94, which is 144% above median its own 10-year median of 7.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predict SpA stock overvalued right now?
Predict SpA (MIL:PRE) has a current EV-to-EBIT of 18.94. The current EV-to-EBIT is 18.94, which is 144% above median its 10-year median of 7.75 and 0.2% below the Medical Devices & Instruments industry median of 18.99. Predict SpA's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Predict SpA (MIL:PRE), the current EV-to-EBIT is 18.94 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Predict SpA develops innovative healthcare technologies, such as Optip and Mistral, and sells medical diagnostic imaging systems. Its products include Versana Active GE, Optic probe, Versana Balance GE, Voluson S-series, and Vivid T8.
16GF Score
Get the complete analysis for MIL:PRE
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PRE has been successfully added to your 
